314 related articles for article (PubMed ID: 9824616)
1. Role of NF-kappaB in immune and inflammatory responses in the gut.
Neurath MF; Becker C; Barbulescu K
Gut; 1998 Dec; 43(6):856-60. PubMed ID: 9824616
[TBL] [Abstract][Full Text] [Related]
2. NF-kappaB regulation in the immune system.
Li Q; Verma IM
Nat Rev Immunol; 2002 Oct; 2(10):725-34. PubMed ID: 12360211
[TBL] [Abstract][Full Text] [Related]
3. Stimulus-selective crosstalk via the NF-κB signaling system reinforces innate immune response to alleviate gut infection.
Banoth B; Chatterjee B; Vijayaragavan B; Prasad MV; Roy P; Basak S
Elife; 2015 Apr; 4():. PubMed ID: 25905673
[TBL] [Abstract][Full Text] [Related]
4. New regulators of NF-kappaB in inflammation.
Ghosh S; Hayden MS
Nat Rev Immunol; 2008 Nov; 8(11):837-48. PubMed ID: 18927578
[TBL] [Abstract][Full Text] [Related]
5. Control of NF-κB and inflammation by the unfolded protein response.
Kitamura M
Int Rev Immunol; 2011 Feb; 30(1):4-15. PubMed ID: 21235322
[TBL] [Abstract][Full Text] [Related]
6. NF-kappaB activation and inhibition: a review.
Sun Z; Andersson R
Shock; 2002 Aug; 18(2):99-106. PubMed ID: 12166787
[TBL] [Abstract][Full Text] [Related]
7. NF-kappaB and the intestine: friend or foe?
Karrasch T; Jobin C
Inflamm Bowel Dis; 2008 Jan; 14(1):114-24. PubMed ID: 17763472
[TBL] [Abstract][Full Text] [Related]
8. Activation of nuclear factor-kappaB in dogs with chronic enteropathies.
Luckschander N; Hall JA; Gaschen F; Forster U; Wenzlow N; Hermann P; Allenspach K; Dobbelaere D; Burgener IA; Welle M
Vet Immunol Immunopathol; 2010 Feb; 133(2-4):228-36. PubMed ID: 19740552
[TBL] [Abstract][Full Text] [Related]
9. Anti-inflammatory interventions of NF-kappaB signaling: potential applications and risks.
Uwe S
Biochem Pharmacol; 2008 Apr; 75(8):1567-79. PubMed ID: 18070616
[TBL] [Abstract][Full Text] [Related]
10. Epithelial NEMO links innate immunity to chronic intestinal inflammation.
Nenci A; Becker C; Wullaert A; Gareus R; van Loo G; Danese S; Huth M; Nikolaev A; Neufert C; Madison B; Gumucio D; Neurath MF; Pasparakis M
Nature; 2007 Mar; 446(7135):557-61. PubMed ID: 17361131
[TBL] [Abstract][Full Text] [Related]
11. The flavonoid luteolin prevents lipopolysaccharide-induced NF-kappaB signalling and gene expression by blocking IkappaB kinase activity in intestinal epithelial cells and bone-marrow derived dendritic cells.
Kim JS; Jobin C
Immunology; 2005 Jul; 115(3):375-87. PubMed ID: 15946255
[TBL] [Abstract][Full Text] [Related]
12. KLF2 in Regulation of NF-κB-Mediated Immune Cell Function and Inflammation.
Jha P; Das H
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29125549
[No Abstract] [Full Text] [Related]
13. The role of nuclear factor-kappaB in inflammatory lung disease.
Imanifooladi AA; Yazdani S; Nourani MR
Inflamm Allergy Drug Targets; 2010 Jul; 9(3):197-205. PubMed ID: 20687892
[TBL] [Abstract][Full Text] [Related]
14. Transcription Factor NF-κB: An Update on Intervention Strategies.
Panday A; Inda ME; Bagam P; Sahoo MK; Osorio D; Batra S
Arch Immunol Ther Exp (Warsz); 2016 Dec; 64(6):463-483. PubMed ID: 27236331
[TBL] [Abstract][Full Text] [Related]
15. Regulation of NF-kappaB signaling by decoy oligodeoxynucleotides.
Isomura I; Morita A
Microbiol Immunol; 2006; 50(8):559-63. PubMed ID: 16924140
[TBL] [Abstract][Full Text] [Related]
16. Role of NF-kappaB activation in intestinal immune homeostasis.
Wullaert A
Int J Med Microbiol; 2010 Jan; 300(1):49-56. PubMed ID: 19781989
[TBL] [Abstract][Full Text] [Related]
17. Anti-inflammatory effects of astroglial α7 nicotinic acetylcholine receptors are mediated by inhibition of the NF-κB pathway and activation of the Nrf2 pathway.
Patel H; McIntire J; Ryan S; Dunah A; Loring R
J Neuroinflammation; 2017 Sep; 14(1):192. PubMed ID: 28950908
[TBL] [Abstract][Full Text] [Related]
18. Identification of novel mediators of NF-kappaB through genome-wide survey of monocyte adherence-induced genes.
Diatchenko L; Romanov S; Malinina I; Clarke J; Tchivilev I; Li X; Makarov SS
J Leukoc Biol; 2005 Dec; 78(6):1366-77. PubMed ID: 16204640
[TBL] [Abstract][Full Text] [Related]
19. NF-κB cellular and molecular regulatory mechanisms and pathways: therapeutic pattern or pseudoregulation?
Haddad JJ; Abdel-Karim NE
Cell Immunol; 2011; 271(1):5-14. PubMed ID: 21777910
[TBL] [Abstract][Full Text] [Related]
20. Suppression of NF-kappaB-dependent proinflammatory gene expression in human RPE cells by a proteasome inhibitor.
Wang XC; Jobin C; Allen JB; Roberts WL; Jaffe GJ
Invest Ophthalmol Vis Sci; 1999 Feb; 40(2):477-86. PubMed ID: 9950608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
